img

Global Kidney Cancer Therapy Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Kidney Cancer Therapy Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Kidney cancer -- also called renal cancer -- is a disease in which kidney cells become malignant (cancerous) and grow out of control, forming a tumor. Almost all kidney cancers first appear in the lining of tiny tubes (tubules) in the kidney. This type of kidney cancer is called renal cell carcinoma.
Renal cell carcinoma (RCC) is a common malignant tumor worldwide, referred to as kidney cancer. According to the World Health Organization, the global incidence of kidney cancer accounts for 2% to 3% of systemic tumors. Among malignant tumors of the urinary system, its incidence is second only to bladder cancer, and it is increasing year by year. In recent years, targeted therapy and precision therapy have become standard treatments for kidney cancer.
Kidney Cancer Therapy report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Kidney Cancer Therapy market is projected to reach US$ 547 million in 2034, increasing from US$ 422.9 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2034. Demand from Renal Cell Carcinoma (RCC) and Transitional Cell Carcinoma (TCC) are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Kidney Cancer Therapy industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Kidney Cancer Therapy key companies include Pfizer, Bristol-Myers Squibb, Roche, GSK, Novartis, Bayer, Merck & Co., Exelixis and Takeda, etc. Pfizer, Bristol-Myers Squibb, Roche are top 3 players and held % share in total in 2022.
Kidney Cancer Therapy can be divided into Monoclonal Antibody, mTOR Inhibitors, Kinase Inhibitors and Other, etc. Monoclonal Antibody is the mainstream product in the market, accounting for % share globally in 2022.
Kidney Cancer Therapy is widely used in various fields, such as Renal Cell Carcinoma (RCC) and Transitional Cell Carcinoma (TCC), etc. Renal Cell Carcinoma (RCC) provides greatest supports to the Kidney Cancer Therapy industry development. In 2022, global % share of Kidney Cancer Therapy went into Renal Cell Carcinoma (RCC) filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Kidney Cancer Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Bristol-Myers Squibb
Roche
GSK
Novartis
Bayer
Merck & Co.
Exelixis
Takeda
Eisai
CTTQ
AVEO Oncology
Everest Pharm
Cipla
NATCO
Beacon Pharma
SAMARTH
Segment by Type
Monoclonal Antibody
mTOR Inhibitors
Kinase Inhibitors
Other

Segment by Application


Renal Cell Carcinoma (RCC)
Transitional Cell Carcinoma (TCC)
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Kidney Cancer Therapy market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Kidney Cancer Therapy introduction, etc. Kidney Cancer Therapy Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Kidney Cancer Therapy market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Kidney Cancer Therapy
1.1 Kidney Cancer Therapy Market Overview
1.1.1 Kidney Cancer Therapy Product Scope
1.1.2 Kidney Cancer Therapy Market Status and Outlook
1.2 Global Kidney Cancer Therapy Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Kidney Cancer Therapy Market Size by Region (2024-2034)
1.4 Global Kidney Cancer Therapy Historic Market Size by Region (2024-2024)
1.5 Global Kidney Cancer Therapy Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Kidney Cancer Therapy Market Size (2024-2034)
1.6.1 North America Kidney Cancer Therapy Market Size (2024-2034)
1.6.2 Europe Kidney Cancer Therapy Market Size (2024-2034)
1.6.3 Asia-Pacific Kidney Cancer Therapy Market Size (2024-2034)
1.6.4 Latin America Kidney Cancer Therapy Market Size (2024-2034)
1.6.5 Middle East & Africa Kidney Cancer Therapy Market Size (2024-2034)
2 Kidney Cancer Therapy Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibody
2.1.2 mTOR Inhibitors
2.1.3 Kinase Inhibitors
2.1.4 Other
2.2 Global Kidney Cancer Therapy Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Kidney Cancer Therapy Historic Market Size by Type (2024-2024)
2.2.2 Global Kidney Cancer Therapy Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Kidney Cancer Therapy Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Kidney Cancer Therapy Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Kidney Cancer Therapy Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Kidney Cancer Therapy Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Kidney Cancer Therapy Revenue Breakdown by Type (2024-2034)
3 Kidney Cancer Therapy Market Overview by Application
3.1 Introduction
3.1.1 Renal Cell Carcinoma (RCC)
3.1.2 Transitional Cell Carcinoma (TCC)
3.2 Global Kidney Cancer Therapy Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Kidney Cancer Therapy Historic Market Size by Application (2024-2024)
3.2.2 Global Kidney Cancer Therapy Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Kidney Cancer Therapy Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Kidney Cancer Therapy Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Kidney Cancer Therapy Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Kidney Cancer Therapy Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Kidney Cancer Therapy Revenue Breakdown by Application (2024-2034)
4 Kidney Cancer Therapy Competition Analysis by Players
4.1 Global Kidney Cancer Therapy Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Kidney Cancer Therapy as of 2022)
4.3 Date of Key Players Enter into Kidney Cancer Therapy Market
4.4 Global Top Players Kidney Cancer Therapy Headquarters and Area Served
4.5 Key Players Kidney Cancer Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Kidney Cancer Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Kidney Cancer Therapy Products, Services and Solutions
5.1.4 Pfizer Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.1.5 Pfizer Recent Developments
5.2 Bristol-Myers Squibb
5.2.1 Bristol-Myers Squibb Profile
5.2.2 Bristol-Myers Squibb Main Business
5.2.3 Bristol-Myers Squibb Kidney Cancer Therapy Products, Services and Solutions
5.2.4 Bristol-Myers Squibb Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.2.5 Bristol-Myers Squibb Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Kidney Cancer Therapy Products, Services and Solutions
5.3.4 Roche Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.3.5 GSK Recent Developments
5.4 GSK
5.4.1 GSK Profile
5.4.2 GSK Main Business
5.4.3 GSK Kidney Cancer Therapy Products, Services and Solutions
5.4.4 GSK Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.4.5 GSK Recent Developments
5.5 Novartis
5.5.1 Novartis Profile
5.5.2 Novartis Main Business
5.5.3 Novartis Kidney Cancer Therapy Products, Services and Solutions
5.5.4 Novartis Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.5.5 Novartis Recent Developments
5.6 Bayer
5.6.1 Bayer Profile
5.6.2 Bayer Main Business
5.6.3 Bayer Kidney Cancer Therapy Products, Services and Solutions
5.6.4 Bayer Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.6.5 Bayer Recent Developments
5.7 Merck & Co.
5.7.1 Merck & Co. Profile
5.7.2 Merck & Co. Main Business
5.7.3 Merck & Co. Kidney Cancer Therapy Products, Services and Solutions
5.7.4 Merck & Co. Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.7.5 Merck & Co. Recent Developments
5.8 Exelixis
5.8.1 Exelixis Profile
5.8.2 Exelixis Main Business
5.8.3 Exelixis Kidney Cancer Therapy Products, Services and Solutions
5.8.4 Exelixis Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.8.5 Exelixis Recent Developments
5.9 Takeda
5.9.1 Takeda Profile
5.9.2 Takeda Main Business
5.9.3 Takeda Kidney Cancer Therapy Products, Services and Solutions
5.9.4 Takeda Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.9.5 Takeda Recent Developments
5.10 Eisai
5.10.1 Eisai Profile
5.10.2 Eisai Main Business
5.10.3 Eisai Kidney Cancer Therapy Products, Services and Solutions
5.10.4 Eisai Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.10.5 Eisai Recent Developments
5.11 CTTQ
5.11.1 CTTQ Profile
5.11.2 CTTQ Main Business
5.11.3 CTTQ Kidney Cancer Therapy Products, Services and Solutions
5.11.4 CTTQ Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.11.5 CTTQ Recent Developments
5.12 AVEO Oncology
5.12.1 AVEO Oncology Profile
5.12.2 AVEO Oncology Main Business
5.12.3 AVEO Oncology Kidney Cancer Therapy Products, Services and Solutions
5.12.4 AVEO Oncology Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.12.5 AVEO Oncology Recent Developments
5.13 Everest Pharm
5.13.1 Everest Pharm Profile
5.13.2 Everest Pharm Main Business
5.13.3 Everest Pharm Kidney Cancer Therapy Products, Services and Solutions
5.13.4 Everest Pharm Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.13.5 Everest Pharm Recent Developments
5.14 Cipla
5.14.1 Cipla Profile
5.14.2 Cipla Main Business
5.14.3 Cipla Kidney Cancer Therapy Products, Services and Solutions
5.14.4 Cipla Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.14.5 Cipla Recent Developments
5.15 NATCO
5.15.1 NATCO Profile
5.15.2 NATCO Main Business
5.15.3 NATCO Kidney Cancer Therapy Products, Services and Solutions
5.15.4 NATCO Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.15.5 NATCO Recent Developments
5.16 Beacon Pharma
5.16.1 Beacon Pharma Profile
5.16.2 Beacon Pharma Main Business
5.16.3 Beacon Pharma Kidney Cancer Therapy Products, Services and Solutions
5.16.4 Beacon Pharma Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.16.5 Beacon Pharma Recent Developments
5.17 SAMARTH
5.17.1 SAMARTH Profile
5.17.2 SAMARTH Main Business
5.17.3 SAMARTH Kidney Cancer Therapy Products, Services and Solutions
5.17.4 SAMARTH Kidney Cancer Therapy Revenue (US$ Million) & (2024-2024)
5.17.5 SAMARTH Recent Developments
6 North America
6.1 North America Kidney Cancer Therapy Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Kidney Cancer Therapy Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Kidney Cancer Therapy Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Kidney Cancer Therapy Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Kidney Cancer Therapy Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Kidney Cancer Therapy Market Dynamics
11.1 Kidney Cancer Therapy Industry Trends
11.2 Kidney Cancer Therapy Market Drivers
11.3 Kidney Cancer Therapy Market Challenges
11.4 Kidney Cancer Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Kidney Cancer Therapy Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Kidney Cancer Therapy Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Kidney Cancer Therapy Market Size Share by Region (2024-2024)
Table 4. Global Kidney Cancer Therapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Kidney Cancer Therapy Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Kidney Cancer Therapy Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Kidney Cancer Therapy Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Kidney Cancer Therapy Revenue Market Share by Type (2024-2024)
Table 9. Global Kidney Cancer Therapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Kidney Cancer Therapy Revenue Market Share by Type (2024-2034)
Table 11. North America Kidney Cancer Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Kidney Cancer Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Kidney Cancer Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Kidney Cancer Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Kidney Cancer Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Kidney Cancer Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Kidney Cancer Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Kidney Cancer Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Kidney Cancer Therapy Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Kidney Cancer Therapy Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Kidney Cancer Therapy Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Kidney Cancer Therapy Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Kidney Cancer Therapy Revenue Market Share by Application (2024-2024)
Table 24. Global Kidney Cancer Therapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Kidney Cancer Therapy Revenue Market Share by Application (2024-2034)
Table 26. North America Kidney Cancer Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Kidney Cancer Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Kidney Cancer Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Kidney Cancer Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Kidney Cancer Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Kidney Cancer Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Kidney Cancer Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Kidney Cancer Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Kidney Cancer Therapy Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Kidney Cancer Therapy Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Kidney Cancer Therapy Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Kidney Cancer Therapy Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Kidney Cancer Therapy as of 2022)
Table 39. Date of Key Players Enter into Kidney Cancer Therapy Market
Table 40. Global Kidney Cancer Therapy Key Players Headquarters and Area Served
Table 41. Kidney Cancer Therapy Product Solution and Service
Table 42. Global Kidney Cancer Therapy Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Pfizer Basic Information List
Table 45. Pfizer Description and Business Overview
Table 46. Pfizer Kidney Cancer Therapy Products, Services and Solutions
Table 47. Revenue (US$ Million) in Kidney Cancer Therapy Business of Pfizer (2024-2024)
Table 48. Pfizer Recent Developments
Table 49. Bristol-Myers Squibb Basic Information List
Table 50. Bristol-Myers Squibb Description and Business Overview
Table 51. Bristol-Myers Squibb Kidney Cancer Therapy Products, Services and Solutions
Table 52. Revenue (US$ Million) in Kidney Cancer Therapy Business of Bristol-Myers Squibb (2024-2024)
Table 53. Bristol-Myers Squibb Recent Developments
Table 54. Roche Basic Information List
Table 55. Roche Description and Business Overview
Table 56. Roche Kidney Cancer Therapy Products, Services and Solutions
Table 57. Revenue (US$ Million) in Kidney Cancer Therapy Business of Roche (2024-2024)
Table 58. Roche Recent Developments
Table 59. GSK Basic Information List
Table 60. GSK Description and Business Overview
Table 61. GSK Kidney Cancer Therapy Products, Services and Solutions
Table 62. Revenue (US$ Million) in Kidney Cancer Therapy Business of GSK (2024-2024)
Table 63. GSK Recent Developments
Table 64. Novartis Basic Information List
Table 65. Novartis Description and Business Overview
Table 66. Novartis Kidney Cancer Therapy Products, Services and Solutions
Table 67. Revenue (US$ Million) in Kidney Cancer Therapy Business of Novartis (2024-2024)
Table 68. Novartis Recent Developments
Table 69. Bayer Basic Information List
Table 70. Bayer Description and Business Overview
Table 71. Bayer Kidney Cancer Therapy Products, Services and Solutions
Table 72. Revenue (US$ Million) in Kidney Cancer Therapy Business of Bayer (2024-2024)
Table 73. Bayer Recent Developments
Table 74. Merck & Co. Basic Information List
Table 75. Merck & Co. Description and Business Overview
Table 76. Merck & Co. Kidney Cancer Therapy Products, Services and Solutions
Table 77. Revenue (US$ Million) in Kidney Cancer Therapy Business of Merck & Co. (2024-2024)
Table 78. Merck & Co. Recent Developments
Table 79. Exelixis Basic Information List
Table 80. Exelixis Description and Business Overview
Table 81. Exelixis Kidney Cancer Therapy Products, Services and Solutions
Table 82. Revenue (US$ Million) in Kidney Cancer Therapy Business of Exelixis (2024-2024)
Table 83. Exelixis Recent Developments
Table 84. Takeda Basic Information List
Table 85. Takeda Description and Business Overview
Table 86. Takeda Kidney Cancer Therapy Products, Services and Solutions
Table 87. Revenue (US$ Million) in Kidney Cancer Therapy Business of Takeda (2024-2024)
Table 88. Takeda Recent Developments
Table 89. Eisai Basic Information List
Table 90. Eisai Description and Business Overview
Table 91. Eisai Kidney Cancer Therapy Products, Services and Solutions
Table 92. Revenue (US$ Million) in Kidney Cancer Therapy Business of Eisai (2024-2024)
Table 93. Eisai Recent Developments
Table 94. CTTQ Basic Information List
Table 95. CTTQ Description and Business Overview
Table 96. CTTQ Kidney Cancer Therapy Products, Services and Solutions
Table 97. Revenue (US$ Million) in Kidney Cancer Therapy Business of CTTQ (2024-2024)
Table 98. CTTQ Recent Developments
Table 99. AVEO Oncology Basic Information List
Table 100. AVEO Oncology Description and Business Overview
Table 101. AVEO Oncology Kidney Cancer Therapy Products, Services and Solutions
Table 102. Revenue (US$ Million) in Kidney Cancer Therapy Business of AVEO Oncology (2024-2024)
Table 103. AVEO Oncology Recent Developments
Table 104. Everest Pharm Basic Information List
Table 105. Everest Pharm Description and Business Overview
Table 106. Everest Pharm Kidney Cancer Therapy Products, Services and Solutions
Table 107. Revenue (US$ Million) in Kidney Cancer Therapy Business of Everest Pharm (2024-2024)
Table 108. Everest Pharm Recent Developments
Table 109. Cipla Basic Information List
Table 110. Cipla Description and Business Overview
Table 111. Cipla Kidney Cancer Therapy Products, Services and Solutions
Table 112. Revenue (US$ Million) in Kidney Cancer Therapy Business of Cipla (2024-2024)
Table 113. Cipla Recent Developments
Table 114. NATCO Basic Information List
Table 115. NATCO Description and Business Overview
Table 116. NATCO Kidney Cancer Therapy Products, Services and Solutions
Table 117. Revenue (US$ Million) in Kidney Cancer Therapy Business of NATCO (2024-2024)
Table 118. NATCO Recent Developments
Table 119. Beacon Pharma Basic Information List
Table 120. Beacon Pharma Description and Business Overview
Table 121. Beacon Pharma Kidney Cancer Therapy Products, Services and Solutions
Table 122. Revenue (US$ Million) in Kidney Cancer Therapy Business of Beacon Pharma (2024-2024)
Table 123. Beacon Pharma Recent Developments
Table 124. SAMARTH Basic Information List
Table 125. SAMARTH Description and Business Overview
Table 126. SAMARTH Kidney Cancer Therapy Products, Services and Solutions
Table 127. Revenue (US$ Million) in Kidney Cancer Therapy Business of SAMARTH (2024-2024)
Table 128. SAMARTH Recent Developments
Table 129. North America Kidney Cancer Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 130. North America Kidney Cancer Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 131. Europe Kidney Cancer Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 132. Europe Kidney Cancer Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 133. Asia-Pacific Kidney Cancer Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 134. Asia-Pacific Kidney Cancer Therapy Market Size by Region (2024-2024) & (US$ Million)
Table 135. Asia-Pacific Kidney Cancer Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 136. Asia-Pacific Kidney Cancer Therapy Market Share by Region (2024-2024)
Table 137. Asia-Pacific Kidney Cancer Therapy Market Share by Region (2024-2034)
Table 138. Latin America Kidney Cancer Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 139. Latin America Kidney Cancer Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 140. Latin America Kidney Cancer Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 141. Middle East & Africa Kidney Cancer Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 142. Middle East & Africa Kidney Cancer Therapy Market Size by Country (2024-2024) & (US$ Million)
Table 143. Middle East & Africa Kidney Cancer Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 144. Kidney Cancer Therapy Market Trends
Table 145. Kidney Cancer Therapy Market Drivers
Table 146. Kidney Cancer Therapy Market Challenges
Table 147. Kidney Cancer Therapy Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Kidney Cancer Therapy Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Kidney Cancer Therapy Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Kidney Cancer Therapy Market Share by Regions: 2022 VS 2034
Figure 4. Global Kidney Cancer Therapy Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Kidney Cancer Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Kidney Cancer Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Kidney Cancer Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Kidney Cancer Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Kidney Cancer Therapy Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Monoclonal Antibody
Figure 11. Global Monoclonal Antibody Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of mTOR Inhibitors
Figure 13. Global mTOR Inhibitors Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Kinase Inhibitors
Figure 15. Global Kinase Inhibitors Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Other
Figure 17. Global Other Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Kidney Cancer Therapy Market Size Share by Type: 2022 & 2034
Figure 19. North America Kidney Cancer Therapy Revenue Market Share by Type (2024-2034)
Figure 20. Europe Kidney Cancer Therapy Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Kidney Cancer Therapy Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Kidney Cancer Therapy Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Kidney Cancer Therapy Revenue Market Share by Type (2024-2034)
Figure 24. Renal Cell Carcinoma (RCC) Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Transitional Cell Carcinoma (TCC) Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Global Kidney Cancer Therapy Market Size Share by Application: 2022 & 2034
Figure 27. North America Kidney Cancer Therapy Revenue Market Share by Application (2024-2034)
Figure 28. Europe Kidney Cancer Therapy Revenue Market Share by Application (2024-2034)
Figure 29. Asia-Pacific Kidney Cancer Therapy Revenue Market Share by Application (2024-2034)
Figure 30. Latin America Kidney Cancer Therapy Revenue Market Share by Application (2024-2034)
Figure 31. Middle East and Africa Kidney Cancer Therapy Revenue Market Share by Application (2024-2034)
Figure 32. Kidney Cancer Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 33. Global Top 5 and Top 10 Players Kidney Cancer Therapy Market Share in 2022
Figure 34. North America Kidney Cancer Therapy Market Share by Country (2024-2034)
Figure 35. United States Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 36. Canada Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 37. Germany Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 38. France Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 39. U.K. Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 40. Italy Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 41. Russia Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 42. Nordic Countries Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 43. Asia-Pacific Kidney Cancer Therapy Market Share by Region (2024-2034)
Figure 44. China Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 45. Japan Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 46. South Korea Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 47. Southeast Asia Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 48. India Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 49. Australia Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 50. Latin America Kidney Cancer Therapy Market Share by Country (2024-2034)
Figure 51. Mexico Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 52. Brazil Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 53. Middle East & Africa Kidney Cancer Therapy Market Share by Country (2024-2034)
Figure 54. Turkey Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 55. Saudi Arabia Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 56. UAE Kidney Cancer Therapy Market Size (2024-2034) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report